Endo International PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ENDPQ Over the counter 2834 http://www.endo.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Endo International PLC

Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® - Mar 26th, 2024 11:30 am
Drugmaker Endo receives US court approval for bankruptcy restructuring - Mar 19th, 2024 10:42 pm
Endo Announces Confirmation of Plan of Reorganization - Mar 19th, 2024 9:30 pm
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution - Mar 12th, 2024 6:00 pm
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS - Mar 6th, 2024 9:15 pm
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER - Feb 29th, 2024 4:43 pm
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open - Jan 24th, 2024 12:30 pm
Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients - Nov 30th, 2023 12:30 pm
Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting - Nov 16th, 2023 12:30 pm
ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS - Nov 6th, 2023 9:05 pm
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting - Sep 21st, 2023 11:45 am
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS - Aug 8th, 2023 11:45 am
Endo Announces First Patient Enrolled in Registry of Peyronie's Disease - Jul 20th, 2023 11:30 am
Endo Launches Bivalirudin Injection in Ready-to-Use Vials - Jul 18th, 2023 8:30 pm
Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) Shortage - Jul 17th, 2023 8:30 pm
Endo Presents New Data at the American Podiatric Medical Association Annual Meeting - Jul 13th, 2023 8:30 pm
Endo Launches First Generic Version of Noxafil® (posaconazole) Injection - Jun 29th, 2023 8:30 pm
Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada - Jun 29th, 2023 11:30 am
Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture - Jun 26th, 2023 11:30 am
Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant® - Jun 15th, 2023 11:30 am